ANNOUNCEMENT: ACCELSIORS CRO OPENS NEW OFFICE IN AUSTRALIA
27 May, 2019 - Adelaide;
Accelsiors today announced the opening of a new subsidiary in Adelaide, Australia. This investment will provide our Biotechnology, Pharmaceutical and Medical Device Customers with greater access to patient populations across the Asia-Pacific region.
“Establishing a new office and permanent presence in Australia provides a scalable and highly capable team supporting all clinical development services and offering further capabilities in support of our increasing clinical trial portfolio. This expansion represents a renewed level of confidence in the quality of service delivery in the region,” said Mihaly Juhasz, MD, Accelsiors’ CEO.
The global clinical drug research and development market is growing at a rapid pace and Accelsiors is positioned to provide an even greater level of support around the world to current and prospective Customers. „Accelsiors is committed to providing our Sponsors with a depth of medical, scientific and regulatory expertise while conducting clinical studies globally with utmost quality,” quoted Dr. Juhasz. “Our 2 decades of experience in the CRO business and ability to provide comprehensive clinical development services has driven us to make this important investment.”
Contact details for Sydney:
Accelsiors CRO and Consultancy Services (Australia) Pvt. Ltd
225 Fullarton Road, Eastwood (Adelaide), SA, Australia